Erratum: CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation (Oncogene (2014) 33 (3677-3687) DOI:10.1038/onc.2013.340);CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation

Oncogene

Volumn 33, Issue 28, 2014, Pages 3677-3687

  Nie, J ^a,b   Liu, L ^a   Xing, G ^b   Zhang, M ^b   Wei, R ^b,c   Guo, M ^a   Li, X ^a   Xie, P ^b   Li, L ^b   He, F ^b,c   Han, W ^a   Zhang, L ^b,d  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^c TSINGHUA UNIVERSITY   (China)

^d DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

CKIP 1; colon cancer; PI3K Akt mTOR signaling; Smurf1; tumor suppression

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 [4 (4 FLUOROPHENYL) 5 (2 METHOXY 4 PYRIMIDINYL) 1 IMIDAZOLYL]CYCLOHEXANOL; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASEIN KINASE 2 INTERACTING PROTEIN 1; CASEIN KINASE II; EOSIN; HEMATOXYLIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; RAPAMYCIN; SHORT HAIRPIN RNA; SMAD PROTEIN; SMURF1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CARCINOGENESIS; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLON ADENOMA; COLON CANCER; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GENE OVEREXPRESSION; GENE SYNTHESIS; HCT116 CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MIGRATION; MIGRATION INHIBITION; MITOSIS; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD UBIQUITYLATION REGULATORY FACTOR 1 ONCOGENE; UBIQUITINATION; UPREGULATION;

ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE PROGRESSION; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; MICE; PROMOTER REGIONS, GENETIC; PROTEOLYSIS; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84904249833     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.28     Document Type: Erratum

References (27)

1. Bosc DG, Graham KC, Saulnier RB, Zhang CJ, Prober D, Gietz RD et al. Identification and characterization of CKIP-1, a novel pleckstrin homology domain-containing protein that interacts with protein kinase CK2. J Biol Chem 2000; 275: 14295-14306. (Pubitemid 30339711)
2. Canton DA, Olsten MEK, Niederstrasser H, Cooper JA, Litchfield DW. The role of CKIP-1 in cell morphology depends on its interaction with actin-capping protein. J Biol Chem 2006; 281: 36347-36359. (Pubitemid 46041369)
3. Safi A, Vandromme M, Caussanel S, Valdacci L, Baas D, Vidal M et al. Role for the pleckstrin homology domain-containing protein CKIP-1 in phosphatidylinositol 3-kinase-regulated muscle differentiation. Mol Cell Biol 2004; 24: 1245-1255. (Pubitemid 38112186)
4. Zhang L, Tang Y, Tie Y, Tian C, Wang J, Dong Y et al. The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell Signal 2007; 19: 932-944. (Pubitemid 46436434)
5. Lu K, Yin X, Weng T, Xi S, Li L, Xing G et al. Targeting WW domains linker of HECT-type ubiquitin ligase Smurf1 for activation by CKIP-1. Nat Cell Biol 2008; 10: 994-1002.
6. Zhang L, Xing G, Tie Y, Tang Y, Tian C, Li L et al. Role for the pleckstrin homology domain-containing protein CKIP-1 in AP-1 regulation and apoptosis. EMBO J 2005; 24: 766-778. (Pubitemid 40396106)
7. Tokuda E, Fujita N, Oh-hara T, Sato S, Kurata A, Katayama R et al. Casein kinase 2- interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo. Cancer Res 2007; 67: 9666-9676. (Pubitemid 47621213)
8. Zhang G, Guo B, Wu H, Tang T, Zhang BT, Zheng L et al. A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med 2012; 18: 307-314.
9. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
10. Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 2004; 74: 1043-1050. (Pubitemid 38568974)
11. Li H, Pamukcu R, Thompson WJ. beta-Catenin signaling: therapeutic strategies in oncology. Cancer Biol Ther 2002; 1: 621-625.
12. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997; 275: 1787-1790. (Pubitemid 27136715)
13. Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988-1004.
14. Zhang B, Halder S, Kashikar N, Cho Y, Datta A, Gorden DL et al. Antimetastatic role of Smad4 signaling in colorectal cancer. Gastroenterology 2010; 138: 969-980.
15. Wang Y, Nie J, Zhang L, Lu K, Xing G, Xie P et al. CKIP-1 couples Smurf1 ubiquitin ligase with Rpt6 subunit of proteasome to promote substrate degradation. EMBO Rep 2012; 13: 1004-1011.
16. Yamashita M, Ying SX, Zhang GM, Li CL, Cheng SY, Deng CX et al. Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 2005; 121: 101-113.
17. Narimatsu M, Bose R, Pye M, Zhang L, Miller B, Ching P et al. Regulation of planar cell polarity by smurf ubiquitin ligases. Cell 2009; 137: 295-307.
18. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGF beta receptors controls epithelial cell plasticity. Science 2005; 307: 1603-1609. (Pubitemid 40354739)
19. Suzuki A, Shibata T, Shimada Y, Murakami Y, Horii A, Shiratori K et al. Identification of SMURF1 as a possible target for 7q21.3-22.1 amplification detected in a pancreatic cancer cell line by in-house array-based comparative genomic hybridization. Cancer Sci 2008; 99: 986-994. (Pubitemid 351997602)
20. Nie J, Liu L, Zhao X, Xie P, Zhou P, Xing G et al. DNA damage stress induces the dissociation of Smurf1/2 from MDM2 in a slow manner. Chinese Sci Bull 2011; 56: 3155-3161.
21. Cui Y, He S, Xing C, Lu K, Wang J, Xing G et al. SCFFBXL15 regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1. EMBO J 2011; 30: 2675-2689.
22. Kannan M, Lee SJ, Schwedhelm-Domeyer N, Stegmuller J. The E3 ligase Cdh1- anaphase promoting complex operates upstream of the E3 ligase Smurf1 in the control of axon growth. Development 2012; 139: 3600-3612.
23. Nie J, Xie P, Liu L, Xing G, Chang Z, Yin Y et al. Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2. J Biol Chem 2010; 285: 22818-22830.
24. Nie J, Liu L, Wu M, Xing G, He S, Yin Y et al. HECT ubiquitin ligase Smurf1 targets the tumor suppressor ING2 for ubiquitination and degradation. FEBS Lett 2010; 584: 3005-3012.
25. Osmundson EC, Ray D, Moore FE, Gao QS, Thomsen GH, Kiyokawa H. The HECT E3 ligase Smurf2 is required for Mad2-dependent spindle assembly checkpoint. J Cell Biol 2008; 183: 267-277.
26. Osmundson EC, Ray D, Moore FE, Kiyokawa H. Smurf2 as a novel mitotic regulator: From the spindle assembly checkpoint to tumorigenesis. Cell Div 2009; 4: 14.
27. Chen X, Zhang H, Wang H, Zhu J, Zhou WY, Zhang H. Transforming growth factor-b1 induces epithelial-to-mesenchymal transition in human lung cancer cells via PI3K/ Akt and MEK/Erk1/2 signaling pathways. Mol Biol Rep 2012; 39: 3549-3556.